Group items tagged

NHS chief executive Amanda Pritchard today (March 1) announced a new campaign to promote early detection of cancer, when it is easier to treat. The campaign, which would run across TV, radio, and social media from Wednesday (March 2), is the first to focus on tackling the fear of cancer rather thanspecific symptoms. It is in line with the NHS Long Term Plan's commitment to increase cancer detection at an early stage by 2028. As per the NHS figures, the number of people getting checked for cancer increased by over half a million between December 2020 and December 2021. Speaking ahead of the launch, Pritchard, said: "We know that the prospect of a cancer diagnosis can be daunting for people and that is exactly why we are launching this potentially lifesaving campaign - we want to allay people's fear about cancer and encourage them to get checked without delay.

Morning friends,today i would like to stress on the importance of screening programmes for early detection of cervical cancer.Cervical cancer is perhaps the most common female genital tract cancer in the developing countries

Jual cytotec misoprostol jakarta misoprostolhotline : call 08574 0559 466. Jual Obat misoprostol Cytotec di Jakarta Bandung.Jogjakarta

MD Anderson Cancer Center and Ascentage Pharma entered into a five-year collaboration that aims to accelerate clinical development of novel apoptosis-targeted and tyrosine kinase inhibitor drug candidates for leukemia treatment. Read the complete report Click on http://bit.ly/2NIzta5

NHS England is set to roll out a new test this week that will help doctors to spot a rare form of eye cancer in babies in the womb. The NHS test developed at Birmingham Women's and Children's NHS Foundation Trust, identifies the risk of developing retinoblastoma in babies that can be monitored and treated sooner - increasing the chance of saving their eyesight and potentially their lives. The new non-invasive test can detect changes in the genes in DNA and is likely to identify around 50 infants with retinoblastoma each year, in the latest example of the NHS harnessing the power of genomics to diagnose and treat patients faster and more effectively. Non-Invasive Prenatal Diagnosis (NIPD) also means parents can be informed early in pregnancy if their child is at risk. "The blood sample test is taken from the mother before birth and tested and analysed for mutations, which can determine with almost 100 per cent accuracy if the baby will develop retinoblastoma," the NHS said.

Molecular diagnostics has the potential to aid early detection and diagnosis of diseases as deadly as cancer and the further advancements...